Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP, BSE: 508869) has completed the acquisition of 90,000 equity shares in Apollo Healthtech Limited (AHTL) for ₹9,00,000, making it a wholly-owned subsidiary. This strategic move enhances Apollo’s capabilities in technology-driven healthcare services, aligning with its digital health expansion strategy.
Transaction Details and Regulatory Compliance
On June 10, 2025, Apollo Hospitals purchased 90,000 equity shares of ₹10 each in AHTL at par value, fulfilling regulatory requirements under SEBI Listing Regulations. The transaction, classified as a related-party deal conducted at arm’s length, required no governmental approvals. AHTL, incorporated on May 15, 2025, operates in pharmaceutical distribution and tech-enabled healthcare services.
Advertisement
The acquisition supports Apollo’s vertical integration strategy, enabling direct control over healthcare technology development and supply chain optimization. As a newly established entity, AHTL has yet to commence commercial operations, with no recorded turnover to date.
Strategic Expansion in Digital Healthcare:
This investment positions AHTL to develop proprietary healthcare technologies under Apollo’s supervision, including telemedicine platforms and AI-driven diagnostic tools. The subsidiary will focus on streamlining pharmaceutical distribution while adhering to Apollo’s quality standards.
Corporate governance protocols ensured transparent disclosure through BSE and NSE filings (Ref: SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123). Apollo Hospitals confirmed no promoter group interests in AHTL beyond this acquisition, maintaining operational independence for the subsidiary.
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
Also read: JK Cement rectifies ₹0.02 Cr error in Saifco acquisition disclosure
Published on: June 9, 2025 / M Vishnu
यज्ज्ञानमाप्यधिकरं।
In this world, there is nothing so sublime as the knowledge of the self.
Dr. Rajagopal, Chief Interventional Cardiologist from Avant BKG Hospitals, Mysuru, will be available for consultation at Shardha Medical on 12th June 2025 at 10:00 AM.
contact: 8277102897
